chr13-110166251-T-G

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.4002A>C​(p.Gln1334His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.328 in 1,606,430 control chromosomes in the GnomAD database, including 88,279 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.31 ( 7518 hom., cov: 32)
Exomes 𝑓: 0.33 ( 80761 hom. )

Consequence

COL4A1
NM_001845.6 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.718
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in the COL4A1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 194 curated pathogenic missense variants (we use a threshold of 10). The gene has 77 curated benign missense variants. Gene score misZ: 3.0194 (below the threshold of 3.09). Trascript score misZ: 4.972 (above the threshold of 3.09). GenCC associations: The gene is linked to brain small vessel disease 1 with or without ocular anomalies, pontine autosomal dominant microangiopathy with leukoencephalopathy, muscular dystrophy-dystroglycanopathy, type A, microangiopathy and leukoencephalopathy, pontine, autosomal dominant, familial porencephaly, autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, retinal arterial tortuosity.
BP4
Computational evidence support a benign effect (MetaRNN=0.013116002).
BP6
Variant 13-110166251-T-G is Benign according to our data. Variant chr13-110166251-T-G is described in ClinVar as [Benign]. Clinvar id is 197520.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-110166251-T-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.34 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.4002A>C p.Gln1334His missense_variant Exon 45 of 52 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.4002A>C p.Gln1334His missense_variant Exon 45 of 52 1 NM_001845.6 ENSP00000364979.4 P02462-1
COL4A1ENST00000650424.1 linkc.156A>C p.Gln52His missense_variant Exon 3 of 10 ENSP00000497477.2 A0A3B3ISV3

Frequencies

GnomAD3 genomes
AF:
0.311
AC:
47236
AN:
151996
Hom.:
7517
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.280
Gnomad AMI
AF:
0.542
Gnomad AMR
AF:
0.265
Gnomad ASJ
AF:
0.399
Gnomad EAS
AF:
0.239
Gnomad SAS
AF:
0.311
Gnomad FIN
AF:
0.268
Gnomad MID
AF:
0.377
Gnomad NFE
AF:
0.343
Gnomad OTH
AF:
0.337
GnomAD3 exomes
AF:
0.304
AC:
76506
AN:
251484
Hom.:
12296
AF XY:
0.313
AC XY:
42501
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.284
Gnomad AMR exome
AF:
0.181
Gnomad ASJ exome
AF:
0.393
Gnomad EAS exome
AF:
0.253
Gnomad SAS exome
AF:
0.338
Gnomad FIN exome
AF:
0.261
Gnomad NFE exome
AF:
0.342
Gnomad OTH exome
AF:
0.339
GnomAD4 exome
AF:
0.330
AC:
479380
AN:
1454316
Hom.:
80761
Cov.:
30
AF XY:
0.331
AC XY:
239763
AN XY:
724036
show subpopulations
Gnomad4 AFR exome
AF:
0.280
Gnomad4 AMR exome
AF:
0.193
Gnomad4 ASJ exome
AF:
0.391
Gnomad4 EAS exome
AF:
0.257
Gnomad4 SAS exome
AF:
0.334
Gnomad4 FIN exome
AF:
0.266
Gnomad4 NFE exome
AF:
0.340
Gnomad4 OTH exome
AF:
0.325
GnomAD4 genome
AF:
0.311
AC:
47251
AN:
152114
Hom.:
7518
Cov.:
32
AF XY:
0.306
AC XY:
22776
AN XY:
74360
show subpopulations
Gnomad4 AFR
AF:
0.280
Gnomad4 AMR
AF:
0.264
Gnomad4 ASJ
AF:
0.399
Gnomad4 EAS
AF:
0.239
Gnomad4 SAS
AF:
0.313
Gnomad4 FIN
AF:
0.268
Gnomad4 NFE
AF:
0.343
Gnomad4 OTH
AF:
0.334
Alfa
AF:
0.335
Hom.:
22371
Bravo
AF:
0.305
TwinsUK
AF:
0.339
AC:
1256
ALSPAC
AF:
0.342
AC:
1319
ESP6500AA
AF:
0.282
AC:
1243
ESP6500EA
AF:
0.341
AC:
2935
ExAC
AF:
0.310
AC:
37612
Asia WGS
AF:
0.259
AC:
901
AN:
3478
EpiCase
AF:
0.353
EpiControl
AF:
0.355

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Jan 15, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jul 15, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Brain small vessel disease 1 with or without ocular anomalies Benign:3
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jun 01, 2017
Athena Diagnostics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Porencephalic cyst Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
14
DANN
Benign
0.88
DEOGEN2
Benign
0.38
T
Eigen
Benign
-0.83
Eigen_PC
Benign
-0.81
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.50
T
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-2.0
N
REVEL
Uncertain
0.34
Sift
Benign
0.12
T
Sift4G
Benign
0.12
T
Polyphen
0.26
B
Vest4
0.055
MutPred
0.25
Gain of catalytic residue at D1330 (P = 0);
MPC
0.59
ClinPred
0.019
T
GERP RS
-1.2
Varity_R
0.067
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3742207; hg19: chr13-110818598; COSMIC: COSV65421515; COSMIC: COSV65421515; API